Terapio is a biopharmaceutical company developing therapeutics based on the RLIP76 protein. Initial applications include developing the RLIP76 protein as a medical countermeasure for radiation exposure and chemical threats to civilian, military, and first responder populations. The RLIP76 protein primarily works though the oxidative stress pathway and provides benefit as both a prophylactic and post exposure treatment.



means therapy in Esperanto, an international, constructed language introduced by Dr. L.L. Zamenhof in 1887.